Oppenheimer acted as Financial Advisor for Evolent Health, Inc.
Oppenheimer & Co. acted as Financial Advisor for Evolent Health, Inc. (NYSE:EVH) on the refinance of $98.3 million of its existing 2021 Convertible Notes for $98.3 million of new 2024 Convertible Notes and raise of additional $18.8 million of cash.
Evolent Health, Inc. is a health care company that delivers proven clinical and administrative solutions to payers and providers in the United States. The company specializes in the areas of care management, network performance, risk adjustment, performance analytics, health plan services, and pharmacy benefit management. The company was founded in 2013 and is based in Arlington, Virginia with additional offices in San Francisco, California; and Chicago, Illinois.
For more information please contact:
Healthcare Investment Banking
|
Marc Cabrera
|
Space
|
Robert Missant
|
|---|---|---|
|
|
Space
|
|
This notice is provided for informational purposes only, and is not intended as a recommendation or an offer or solicitation for the purchase or sale of any security or financial instrument. Nothing contained herein shall constitute an offer or solicitation to buy or sell any securities discussed herein in any jurisdiction where such offer or solicitation would be prohibited.
This notice may contain statistical data cited from third-party sources believed to be reliable, but Oppenheimer & Co. Inc. does not represent that any such third-party statistical information is accurate or complete, and it should not be relied upon as such. All market prices, data and other information are not warranted as to completeness or accuracy and are subject to change without notice.
2020 Oppenheimer & Co. Inc. Transacts Business on all Principal Exchanges and Member SIPC 3123772.1